Evoke Wealth’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-45,948
Closed -$9.83M 371
2026
Q1
$9.83M Sell
45,948
-4,184
-8% -$936K 0.18% 56
2025
Q4
$8.59M Buy
50,132
+39,624
+377% +$6.16M 0.16% 63
2025
Q3
$1.41M Buy
10,508
+2,543
+32% +$269K 0.03% 211
2025
Q2
$777K Buy
7,965
+768
+11% +$60.9K 0.02% 266
2025
Q1
$525K Buy
+7,197
New +$567K 0.01% 269
2024
Q2
Sell
-2,080
Closed -$203K 265
2024
Q1
$203K Buy
+2,080
New +$183K 0.01% 382
2022
Q4
Sell
-190
Closed -$7K 805
2022
Q3
$7K Hold
190
﹤0.01% 825
2022
Q2
$8K Sell
190
-100
-34% -$4.76K ﹤0.01% 809
2022
Q1
$16K Buy
290
+70
+32% +$4.08K ﹤0.01% 692
2021
Q4
$16K Hold
220
﹤0.01% 715
2021
Q3
$12K Sell
220
-1,060
-83% -$64.5K ﹤0.01% 715
2021
Q2
$83K Buy
1,280
+680
+113% +$42.9K ﹤0.01% 465
2021
Q1
$36K Buy
600
+360
+150% +$19.6K ﹤0.01% 492
2020
Q4
$11K Sell
240
-1,230
-84% -$51.7K ﹤0.01% 577
2020
Q3
$49K Buy
1,470
+1,300
+765% +$44.8K ﹤0.01% 360
2020
Q2
$6K Sell
170
-40
-19% -$1.09K ﹤0.01% 633
2020
Q1
$5.07K Sell
210
-310
-60% -$8.93K ﹤0.01% 603
2019
Q4
$15.3K Buy
520
+60
+13% +$1.59K ﹤0.01% 654
2019
Q3
$10.7K Buy
+460
New +$9.66K ﹤0.01% 804

Other funds holding LRCX

Evoke Wealth's LRCX Position: Q2 2026 in Review

Evoke Wealth sold out of Lam Research (LRCX) in Q2 2026, closing a stake of 45,948 shares — an estimated $9.83M sold.

Evoke Wealth first reported a position in LRCX in Q3 2019 and held it in 19 quarters. The position peaked at $9.83M in Q1 2026. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Evoke Wealth reported no remaining Lam Research position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 45,948 Lam Research shares in Q2 2026, an estimated $9.83M.
  • Evoke Wealth first reported a position in Lam Research in Q3 2019 and held it in 19 quarters.
  • Evoke Wealth's Lam Research position peaked at $9.83M in Q1 2026.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.